Twist Bioscience Q3 Results Top Estimates
(RTTNews) - Genomics company Twist Bioscience Corp. (TWST) reported Friday a net loss attributable to common stockholders for the third quarter of $60.52 million or $1.08 per share, wider than $40.04 million or $0.82 per share in the prior-year quarter.
On average, seven analysts polled by Thomson Reuters expected the company to report a loss of $1.31 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues for the quarter increased to $56.11 million from $35.02 million in the same quarter last year. Analysts expected revenues of $51.45 million for the quarter.
Looking ahead to fiscal 2022, the company now projects revenue of approximately $203 million, up from the prior guidance range of $191 million to $199 million.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Twist Bioscience Inks Antibody Discovery, Option And License Deal With Bayer For Up To $188 Mln
U.S. Jobless Claims Unexpectedly Edge Down To 206,000
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
U.S. Producer Prices Increase In Line With Estimates In August
U.S. Weekly Jobless Claims Unexpectedly Edge Slightly Lower
Lower Open Likely On Bay Street
FTSE 100 Down 0.31% As Oil Surge Stokes Rate-Hike Worries
